Supporting Holistic Health Low-dose GLP-1 therapy can complement other functional medicine interventions like nutritional optimization, stress management, and lifestyle modifications
Increased serum levels of human pancreatic polypeptide (HPP), gastrin, motilin, CCK, PYY, ghrelin, and also GIP, GLP-1, and GLP-2 have been reported either at baseline or postprandially in UC and/or CD (154, 163, 165168)
Specifically, individual treatment with the amylin agonist sCT or with the GLP-1R agonist, liraglutide, successfully decreased 24 h body weight change and food intake at 1, 3, 6 and 24 h post-injection (Fig
Beyond losing weight, semaglutide helps enhance overall health, reducing risks associated with chronic diseases
Lab work coordination: Does the platform help coordinate lab work
Hormone Metab Res